This is a Validated Antibody Database (VAD) review about human CCL22, based on 3 published articles (read how Labome selects the articles), using CCL22 antibody in all methods. It is aimed to help Labome visitors find the most suited CCL22 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCL22 synonym: A-152E5.1; ABCD-1; DC/B-CK; MDC; SCYA22; STCP-1; C-C motif chemokine 22; CC chemokine STCP-1; MDC(1-69); chemokine (C-C motif) ligand 22; macrophage-derived chemokine; small inducible cytokine A22; small inducible cytokine subfamily A (Cys-Cys), member 22; stimulated T cell chemotactic protein 1
Abcam
rabbit monoclonal (EPR1362) |
| Abcam CCL22 antibody (Abcam, EPR1362) was used in flow cytometry on mouse samples (fig 3e). Front Immunol (2018) ncbi |
rabbit polyclonal |
| Abcam CCL22 antibody (Abcam, ab9847) was used in immunohistochemistry - paraffin section on human samples at 1:40. PLoS ONE (2013) ncbi |
R&D Systems
mouse monoclonal (57203) |
| In order to investigate the basis for T regulatory cell accumulation in melanoma, R&D Systems CCL22 antibody (R&D Systems, 57203) was used in immunohistochemistry - frozen section on human samples (fig 2d). Cancer Res (2016) ncbi |
Articles Reviewed
- Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
articles
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments